American Statistical Association
Cancer epidemiology studies often establish a parent population to investigate the etiologic effects of risk factors. Some putative risk factors such as demographic and behavioral characteristics are evaluated on the entire population, and new risk factors such as biomarkers (for example, sequence variants or expressions) are frequently examined as the study continues. Evaluating biomarkers on the entire parent population may not always be feasible due to logistic or cost reasons. This talk will examine the characteristics of a novel stratified sampling scheme to identify informative individuals for biomarker studies.
|Date:||Wednesday, March 12, 2008|
|Time:||4:00 P.M. - 5:00 P.M.|
Memorial Sloan-Kettering Cancer Center
Department of Epidemiology and Biostatistics
307 East 63rd Street
(between First and Second Avenues)
3rd Floor Conference Room
New York, New York
Note: To gain access to the building, please follow the directions by the telephone in the foyer.